Current Landscape of Therapeutic Resistance in Lung Cancer and Promising Strategies to Overcome Resistance
Lung cancer is one of the leading causes of cancer-related deaths worldwide with a 5-year survival rate of less than 18%. Current treatment modalities include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. Despite advances in therapeutic options, resistance to therapy...
Main Authors: | Adnin Ashrafi, Zakia Akter, Pouya Modareszadeh, Parsa Modareszadeh, Eranda Berisha, Parinaz Sadat Alemi, Maria del Carmen Chacon Castro, Alexander R. Deese, Li Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/19/4562 |
Similar Items
-
An Analysis of the Multifaceted Roles of Heme in the Pathogenesis of Cancer and Related Diseases
by: Tianyuan Wang, et al.
Published: (2021-08-01) -
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin
by: Nanumi Han, et al.
Published: (2023-12-01) -
Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives
by: Rokeya Akter, et al.
Published: (2021-10-01) -
Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer
by: Xiaowen Qi, et al.
Published: (2022-11-01) -
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance
by: Ting-Wan Kao, et al.
Published: (2023-07-01)